Posters
Breast cancer 2025
| P01 | Studying the effectiveness of psychotherapy based on acceptance and commitment on anxiety and depression and quality of parent-child relationship in mothers with breast cancer and their children Leila Dehghanian, Iran |
| P02 | Primary breast lymphoma: A single centre experience Jaime Seah, Singapore |
| P03 | Incidence of cancer related fatigue (CRF) in Indian women with breast cancer; an overview of psychosocial issues in breast cancer patients receiving chemotherapy Vineet Talwar, India |
Breast cancer genetics
| P04 | The efficacy of neoadjuvant chemotherapy for breast cancer in BRCA1 and BRCA2 mutation carriers Arisa Ata, Japan |
| P05 | Quality of life according to risk-reducing salpingo-oophorectomy in Korean BRCA carriers Eunyoung Kang, Korea |
| P06 | Clinical outcomes according to BRCA gene status in breast cancer patients. Can the BRCA gene mutation be used as a prognostic factor for breast cancer? Jong Eun Lee, Korea |
| P07 | BRCA1/BRCA2 mutations in Japanese women with ductal carcinoma in situ Yan Liu, China |
| P08 | Culturally cancer risk counseling and education for underserved Latinas Lina Mayorga, USA |
| P09 | Risk reduction mastectomy in BRCA mutation carriers Junko Takei, Japan |
Breast cancer screening
| P10 | Borderline lesions diagnosed on breast core biopsy: Frequency of atypia and carcinoma on surgical excision – local clinical experience Henry Bevis, Australia |
| P11 | Early detection of breast cancer with albumin and hemoglobin adducts of estrogen quinone Dar-Ren Chen, Chinese Taipei |
| P12 | Effects of breast cancer open biopsy on the status of axillary lymph node metastasis Yin Yin Chen, Chinese Taipei |
| P13 | Pure mucocele-like lesions of the breast: Is there a role for open biopsy after core needle biopsy? Kok On Ho, Singapore |
| P14 | Breast cancer treatment delays among young women in a developing country Monica Rivera Franco, Mexico |
Breast imaging
| P15 | An efficient gradient-distortion method for accurate diagnosis of human organ medical image Daewon Chung, Korea |
| P16 | Tumor size and proliferative marker geminin rather than Ki67 expression levels were significantly associated with maximum uptake of 18F-deoxyglucose levels on positron emission tomography for breast cancers Yukie Fujimoto, Japan |
| P17 | Computed tomography liver spleen ratio as predictive marker of liver injury among adult Filipina early breast cancer receiving neoadjuvant therapy from 2010-2016: A six-year retrospective study Amabelle Trina Gerona, Philippines |
| P18 | Breast tissue stability of the SAVI SCOUT reflector from implantation to excision: A post-hoc analysis from a prospective multi-site trial Jiyon Lee, USA |
Breast reconstruction
| P19 | Mastectomy skin flap perfusion when using PICO® “negative pressure wound dressing” therapy Henry Bevis, Australia |
| P20 | Lipofilling as bridge to implant-based delayed breast reconstruction in post- mastectomy radiation therapy patient Jendana Chanyaputhipong, Thailand |
| P21 | Comparison between negative pressure wound therapy on partial mammectomy scar and dry dressing in a patient with high risk factor of bad healing Clément Dabiri, France |
| P22 | Management of central tumors with the Grisotti technique Clément Dabiri, France |
| P23 | Breast oncoplastic operations in breast cancer patients with unfavorable prognostic features Valerijus Ostapenko, Lithuania |
Her2 positive breast cancer
| P24 | The efficacy and tolerability of T-DM1 in Japanese HER2 positive metastatic breast cancer patients Kei Komatsu, Japan |
| P25 | Significance of Ki67 in predicting response to neoadjuvant chemotherapy in HER2- positive breast cancer patients Haruna Sakai, Japan |
| P26 | The experiences of the use of T-DM1 for distant metastases in HER2-positive breast cancer Terumasa Sawada, Japan |
Local and locoregional therapy
| P27 | Comparison of sentinel lymph node biopsy between invasive lobular carcinoma and invasive ductal carcinoma Yayoi Adachi, Japan |
| P28 | The characteristics and management of outcomes in older women with breast cancer in New Zealand Tania Blackmore, New Zealand |
| P29 | Manpower and resource planning for setting up a deep inspiratory breath hold (DIBH) radiation therapy: A prospective study Sanjoy Chatterjee, India |
| P30 | Comparison of AJCC 8th and 7th edition staging for carcinoma breast: A survival analysis Kunal Choudhary, India |
| P31 | Discordance of hormone receptor and human epidermal growth factor receptor2 as a prognostic factor of survival between primary breast cancer and recurrent breast cancer Euitae Kim, Korea |
| P32 | Is supraclavicular lymph node dissection recommended for clinical N3c breast cancer after neoadjuvant chemotherapy? Joo Heung Kim, Korea |
| P33 | Mastectomy or breast conservation surgery in early breast cancer? Factors affecting patient choice Luyu Kuo, Australia |
| P34 | Characteristics and treatment for breast cancer for Asian and Pacific women in New Zealand Chunhuan Lao, New Zealand |
| P35 | Will systemic adjuvant therapy be necessary after concerving breast recurrences? Misaki Matsuyanagi, Japan |
| P36 | Is reliable to preserve lymphatics of the arm in axilla and reduced occurence of lymphedema in breast cancer patient with axila surgery ? The anatomical study David Pavlišta, Czech Republic |
| P37 | Factors influencing reoperation following breast conserving surgery Andrew Philpott, Australia |
| P38 | Paget’s disease of the breast. A clinicopathologic study Nikolaos Salemis, Greece |
| P39 | Male breast cancer. Diagnostic evaluation and management. A clinicopathologic study Nikolaos Salemis, Greece |
| P40 | Invasive micropapillary carcinoma of the breast. A rare presentation of an agrressive malignancy and review of the literature Nikolaos Salemis, Greece |
| P41 | Axillary dissection after sentinel lymph node biopsy: Are updated ASCO guidelines universally applicable? Prafulla Shakya, Nepal |
| P42 | Thirty-six cases that were clinically node positive at diagnosis and underwent sentinel node biopsy after neoadjuvant chemotherapy followed by omitting axillary dissection Yumiko Taki, Japan |
| P43 | The impact of classification on breast conservation rates for multifocal and multicentric breast cancers Mona P. Tan, Singapore |
| P44 | Video-assisted breast sugery (VABS) excels in the treatment results and the postoperative aesthetic results Koji Yamashita, Japan |
| P45 | Pre-operative ultrasound guidance combined with a carbon nanoparticle tracer for sentinel lymph node biopsy in breast cancer patients Liulu Zhang, China |
Molecular assays
| P46 | The use of oncotype DX to evaluate the significance of HER2 protein expression in hormone-positive breast cancer Yoko Kanada, Japan |
| P47 | Trail sensitizes cystidine deprivation-mediated cell death in hypoxia Mi Ri Kim, Korea |
| P48 | Aloe-emodin enhances tamoxifen cytotoxicity by suppressing Ras/ERK and PI3K/mTOR in breast cancer cells Hung Ting Lin, Chinese Taipei |
| P49 | HIF-1alpha K674 acetylation by trichostatin a is associated with drug resistance induction under normoxic conditions Eun Yi Moon, Korea |
| P50 | Predictive value of the 21-gene recurrence score for invasive lobular carcinoma Mamika Nakamura, Japan |
| P51 | Clinical characteristics of the breast cancer patients treated with chemotherapy by the histoculture drug response assay at a single institution Sang Eun Nam, Korea |
| P52 | Downregulation of breast carcinoma amplification sequence 1 (BCAS1) overcomes tamoxifen-resistant in breast cancer cells In-Chul Park, Korea |
| P53 | The expression of human epididymis protein 4 in breast cancer Shyr-Ming Sheen-Chen, Chinese Taipei |
| P54 | The current status of 21-gene signature in early breast cancer patients with hormone receptor positive at single institution in Japan Mitsuo Terada, Japan |
| P55 | Clinical and potential molecular parameters for predicting recurrence of patients diagnosed with breast phyllodes tumors Ya-Wen Yang, Chinese Taipei |
Neoadjuvant therapy
| P56 | Prognostic effect of sentinel lymph node biopsy after neoadjuvant chemotherapy in node-positive breast cancer Choi Hee Jun, Korea |
| P57 | Anti-cancer synergy effects for anemarrhena asphodeloides bunge and Coptis chinensis using conditionally reprogrammed breast cancer cell and breast cancer cell lines Chang-Ho Jeon, Korea |
| P58 | Neuroendocrine breast carcinoma: Can surgery be avoided? Jacques Marnewick, New Zealand |
Triple negative breast cancer
| P59 | The role of L1 retrotransposons in triple negative breast cancer Pey-Tsyr Chiou, Australia |
| P60 | Differences in triorganometallics-induced cytotoxicity and modulation of migration in triple-negative breast cancer cell line mda-mb-231 Luba Hunakova, Slovakia |
| P61 | High PD-L1 expression is closely associated with tumor-infiltrating lymphocytes and leads to good clinical outcomes in Chinese triple negative breast cancer patients Ying Lin, China |
| P62 | Appropriate management for elderly patients with triple negative breast cancer Ayuha Yoshizawa, Japan |